The big news in health care last week was, of course, that average annual premiums for family coverage through employers reached an all-time high of $15,037, a nine percent increase from last year. While the major media outlets were scrambling to make sense out of such a steep rise, I was walking the streets of Lincoln, Nebraska, hearing from people about the troubles they had keeping their families insured. One thirty-five-year-old man, eager to dump his individual policy that cost too much and covered too little, explained that he hoped to get his family on his wife’s employer plan from an optical company, but that plan had been too expensive for them, even with the company paying part of the premium. The employer is now switching to a cheaper plan, although with higher cost-sharing. Still, he thought they might sign up for it this fall. The numbers out from the Kaiser Family Foundation confirmed his pain.

The premium increases made page one of the Lincoln Journal Star. I eagerly read the piece, which was a wire story from the Los Angeles Times. I waded through lots of numbers, alongside a predictable quote from Kaiser president Drew Altman, who said that “a big premium jump is especially tough for workers. It’s really tough for workers when wages are declining in real terms.” The Times amplified Altman’s point, reporting that health benefits have grown 168 percent since 1999—more than three times the rate of earnings growth and more than four times the rate of inflation. I looked for some fact that would tell me something about medical trend—jargon for changes in health care costs—declining, as it was earlier this year. Yet the Times story indicated the trend was up.

I recalled a Wall Street Journal story in late July that reported Americans are using fewer medical services, and that a drop in usage is showing up as insurers report their financial results. “People just aren’t using health-care like they have,” said WellPoint’s chief financial officer. “The recent drop in usage could make it difficult for insurers to argue that continued price increases are necessary,” the Journal concluded. In other words, premium increases should be moderating.

That point was made by my other sources, citing the Standard & Poor’s Healthcare Economic Composite Index from earlier this year. The index had posted its lowest annual growth rate in its six-year history. I searched the LA Times story for some explanation of this. No luck, although the story said twice that experts expect health expenses to slow next year.

So I checked other coverage for some kind of explanation of the apparent decline in medical trend and the huge premium increases, starting naturally with the Wall Street Journal, which did note that the increases come “despite a continued trend toward more limited use of medical services in the U.S.” An analyst from Goldman Sachs said carriers may have been conservative in their pricing, and overshot to some degree. Altman said the premium hike could be attributed to projections that consumers would use more health care services than they did, continued increases in health care prices, insurance company profits, and to some extent the new health reform law.

A story from McClatchy’s Washington bureau reported “profits continue to pour in for insurers who are spending less for services as covered workers postpone doctor visits and other elective procedures during the economic downturn,” citing a quarterly report from the Bureau of Labor Statistics. Reed Abelson and Nina Bernstein of The New York Times also acknowledged this downward trend, but made clear that hospitals and drug makers were charging more. They built their piece on large rate increases in New York. Aetna, for example, has asked for increases ranging from 8.9 percent to 53.6 percent. One Emblem Health policyholder got notice of a 270 percent increase. Ever since health insurers asked for huge increases in California last year, Campaign Desk has been urging news outlets in other states to tackle the subject, so it was good to see Abelson and Bernstein move their story in this direction rather than repeat an outline of Kaiser’s report.

Trudy Lieberman is a fellow at the Center for Advancing Health and a longtime contributing editor to the Columbia Journalism Review. She is the lead writer for The Second Opinion, CJR’s healthcare desk, which is part of our United States Project on the coverage of politics and policy. Follow her on Twitter @Trudy_Lieberman.